|
Market Closed -
NYSE
16:00:03 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 86.52 USD | +0.53% |
|
+0.30% | +9.49% |
| 09-28 | BNP Paribas Adjusts PT on Colgate-Palmolive to $97 From $101, Keeps Outperform Rating | MT |
| 09-21 | Piper Sandler Adjusts PT on Colgate-Palmolive to $95 From $98, Maintains Overweight Rating | MT |
Company Valuation: Colgate-Palmolive Company
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 71,929 | 65,807 | 65,631 | 74,274 | 63,695 | 68,971 | - | - |
| Change | - | -8.51% | -0.27% | 13.17% | -14.24% | 8.28% | - | - |
| Enterprise Value (EV) 1 | 78,342 | 73,798 | 73,214 | 81,127 | 70,395 | 75,694 | 75,404 | 75,008 |
| Change | - | -5.8% | -0.79% | 10.81% | -13.23% | 7.53% | -0.38% | -0.53% |
| P/E | 33.5x | 37x | 28.8x | 25.9x | 30x | 23.6x | 22x | 20.6x |
| PBR | 118x | 164x | 108x | 353x | 1,186x | 125x | 76.7x | 49.6x |
| PEG | - | -2.2x | 1x | 1x | -1.2x | 0.6x | 3.11x | 2.9x |
| Capitalization / Revenue | 4.13x | 3.66x | 3.37x | 3.7x | 3.13x | 3.22x | 3.13x | 3.02x |
| EV / Revenue | 4.5x | 4.11x | 3.76x | 4.04x | 3.45x | 3.54x | 3.42x | 3.28x |
| EV / EBITDA | 17.7x | 17.5x | 15.9x | 16.4x | 14.1x | 14.9x | 14.1x | 13.3x |
| EV / EBIT | 20.2x | 20x | 18.1x | 18.6x | 16.2x | 17.1x | 16.1x | 15.1x |
| EV / FCF | 28.4x | 39.7x | 24.1x | 22.9x | 19.4x | 26.3x | 21.7x | 20.1x |
| FCF Yield | 3.52% | 2.52% | 4.15% | 4.37% | 5.16% | 3.8% | 4.6% | 4.96% |
| Dividend per Share 2 | 1.79 | 1.86 | 1.91 | 1.98 | 2.06 | 2.119 | 2.192 | 2.272 |
| Rate of return | 2.1% | 2.36% | 2.4% | 2.18% | 2.61% | 2.45% | 2.53% | 2.63% |
| EPS 2 | 2.55 | 2.13 | 2.77 | 3.51 | 2.63 | 3.67 | 3.93 | 4.209 |
| Distribution rate | 70.2% | 87.3% | 69% | 56.4% | 78.3% | 57.7% | 55.8% | 54% |
| Net sales 1 | 17,421 | 17,967 | 19,457 | 20,101 | 20,382 | 21,402 | 22,065 | 22,848 |
| EBITDA 1 | 4,433 | 4,226 | 4,603 | 4,958 | 4,977 | 5,092 | 5,355 | 5,640 |
| EBIT 1 | 3,877 | 3,681 | 4,036 | 4,353 | 4,347 | 4,419 | 4,688 | 4,973 |
| Net income 1 | 2,166 | 1,785 | 2,300 | 2,889 | 2,132 | 2,837 | 3,114 | 3,302 |
| Net Debt 1 | 6,413 | 7,991 | 7,583 | 6,853 | 6,700 | 6,722 | 6,433 | 6,036 |
| Reference price 2 | 85.34 | 78.79 | 79.71 | 90.91 | 79.02 | 86.52 | 86.52 | 86.52 |
| Nbr of stocks (in thousands) | 842,849 | 835,214 | 823,372 | 817,011 | 806,065 | 797,173 | - | - |
| Announcement Date | 1/28/22 | 1/27/23 | 1/26/24 | 1/31/25 | 1/30/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 23.4x | 3.52x | 14.79x | 2.47% | 68.6B | |
| 21.48x | 4.1x | 15.01x | 3.01% | 340B | |
| 18.23x | 2.72x | 11.99x | 3.53% | 133B | |
| 40.44x | 6.49x | 28.17x | 2.32% | 47.63B | |
| 18.75x | 2.65x | 11.04x | 4.74% | 34.19B | |
| 32.33x | 2.52x | 13.99x | 1.69% | 34.18B | |
| 22.73x | 1.66x | 10.59x | 2.22% | 20.2B | |
| 20.71x | 1.34x | 8.75x | 1.27% | 19.52B | |
| 15.09x | 1.45x | 8.2x | 3.54% | 17.7B | |
| 38.02x | 5.34x | 26.23x | 1.9% | 9.39B | |
| Average | 25.12x | 3.18x | 14.88x | 2.67% | 72.41B | |
| Weighted average by Cap. | 22.77x | 3.61x | 14.75x | 2.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CL Stock
- Valuation Colgate-Palmolive Company
Select your edition
All financial news and data tailored to specific country editions
